- Related capabilities
Accessing capital is critical to our clients and their businesses. Our Equity Capital Markets team members are experts in navigating the complex legal and regulatory frameworks that apply to equity transactions, enabling our clients to secure the capital they need to achieve their goals.
We assist listed companies of varying sizes and in a diverse range of industries, as well as major shareholders, lead managers and underwriters. We advise on the full range of public markets transactions, including initial public offerings (IPOs), backdoor listings and secondary fundraisings (such as placements, rights issues and share purchase plans).
We also advise investors and issuers on equity transactions in the private markets, including seed offerings through to Series A, B, C and pre-IPO funding rounds.
We work collaboratively and proactively with clients and their other advisers, such as investment banks and accountants. Our clients also benefit from our good working relationships with the Australian Securities Exchange (ASX) and the Australian Securities and Investments Commission (ASIC), which enable us to assist our clients navigate the regulatory landscape applying to equity transactions.
advised Bega on its IPO and listing on the ASX. Following its listing, we advised Bega on its:
- institutional placement and share purchase plan to raise $160 million to fund the acquisition of the Mondelēz Australian and New Zealand grocery business.
- institutional placement and share purchase plan to raise $250 million.
institutional placement and entitlement offer to raise. - $400 million to fund the acquisition of the Lion Dairy & Drinks group.
advised pharmaceutical and drug discovery company Nyrada on an IPO of CDIs and its ASX listing, which involved the complexities of listing on the ASX as an entity incorporated in the United States.
advised national fitout and construction company SHAPE on its IPO and listing on the ASX.
advised FMCG business and food exporter SunRice on its move from a listing on the National Stock Exchange of Australia (NSX) to an ASX listing, which involved a novel structure and quotation of non-voting shares on the ASX.
advised New Zealand Exchange (NZX)-listed medical device company, TruScreen, on its listing on the ASX as a Foreign Exempt Listing.
advised agri-tech company, The Yield, on its $11 million raising, led by Yamaha Motor Venture.
